
Teplizumab: the FDA’s decision still gives hope for a type 1 diabetes immunotherapy
"Although today’s news wasn’t exactly what we hoped for, it is not the end for teplizumab"
Read Conor's story
| 06 July 2021
Read Conor's story
| 06 July 2021
Read Caroline's story
| 28 June 2021
Read Sophia's story
| 23 June 2021
Read Sara and Tim's story
| 17 June 2021
Read Les's story
| 16 June 2021
Read Roman's story
| 03 June 2021
Read Colin's story
| 26 May 2021
Read Conor's story
| 19 May 2021
Read Jonty's story
| 22 April 2021
By continuing to use the site, you agree to the use of cookies. More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.